Gentile et al. [59] retrospectively analyzed 85 patients with triple-negative or HER2-enriched ipsilateral breast cancer recurrence and found no significant difference in disease-free survival between second breast-conserving surgery and salvage mastectomy (p = 0.596). This evidence concerns the gene ERBB2 and breast cancer.